The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Akari Therapeutics Plc | COM | 00972G108 | 5,173 | 369,490 | SH | SOLE | 369,490 | 0 | 0 | ||
| Alcobra Ltd | COM | M2239P109 | 4,285 | 1,130,500 | SH | SOLE | 1,130,500 | 0 | 0 | ||
| ARCA biopharma Inc | COM | 00211Y100 | 3,744 | 1,078,932 | SH | SOLE | 1,078,932 | 0 | 0 | ||
| Ascendis Pharma A/S | COM | 04351P101 | 13,377 | 721,152 | SH | SOLE | 721,152 | 0 | 0 | ||
| Avalanche Biotechnologies Inc | COM | 05337G107 | 1,448 | 280,000 | SH | SOLE | 280,000 | 0 | 0 | ||
| AveXis Inc | COM | 05366U100 | 24,501 | 1,035,657 | SH | SOLE | 1,035,657 | 0 | 0 | ||
| Axovant Sciences Ltd | COM | G0750W104 | 4,932 | 429,590 | SH | SOLE | 429,590 | 0 | 0 | ||
| BioCryst Pharmaceuticals Inc | COM | 09058V103 | 13,271 | 4,689,435 | SH | SOLE | 4,689,435 | 0 | 0 | ||
| BeiGene Ltd | COM | 07725L102 | 3,488 | 119,000 | SH | SOLE | 119,000 | 0 | 0 | ||
| Coherus Biosciences Inc | COM | 19249H103 | 5,504 | 259,259 | SH | SOLE | 259,259 | 0 | 0 | ||
| Cynapsus Therapeutics Inc | COM | 23257Y701 | 3,073 | 253,345 | SH | SOLE | 253,345 | 0 | 0 | ||
| CytomX Therapeutics Inc | COM | 23284F105 | 7,429 | 577,831 | SH | SOLE | 577,831 | 0 | 0 | ||
| DBV Technologies | COM | F2927N109 | 12,204 | 214,417 | SH | SOLE | 214,417 | 0 | 0 | ||
| Edge Therapeutics Inc | COM | 279870109 | 17,692 | 1,933,582 | SH | SOLE | 1,933,582 | 0 | 0 | ||
| Global Blood Therapeutics | COM | 37890U108 | 2,701 | 170,312 | SH | SOLE | 170,312 | 0 | 0 | ||
| Heron Therapeutics Inc | COM | 427746102 | 7,708 | 405,901 | SH | SOLE | 405,901 | 0 | 0 | ||
| Lipocine Inc | COM | 53630X104 | 4,263 | 420,000 | SH | SOLE | 420,000 | 0 | 0 | ||
| Ocera Therapeutics | COM | 67552A108 | 2,788 | 948,372 | SH | SOLE | 948,372 | 0 | 0 | ||
| ProNAI Therapeutics Inc | COM | 74346L101 | 882 | 130,798 | SH | SOLE | 130,798 | 0 | 0 | ||
| REGENXBIO Inc | COM | 75901B107 | 11,134 | 1,030,954 | SH | SOLE | 1,030,954 | 0 | 0 | ||
| Stemline Therapeutics Inc | COM | 85858C107 | 1,472 | 315,980 | SH | SOLE | 315,980 | 0 | 0 | ||
| Zafgen Inc | COM | 98885E103 | 945 | 141,479 | SH | SOLE | 141,479 | 0 | 0 | ||